VC firm
Petrichor Healthcare
Also known as PETRICHOR SCION THERAPEUTICS, PETRICHOR SCION THERAPEUTICS LLC
- Investor type
- VC
- Investing status
- Activeas of 2026-09-21Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Founded
- 2018
- Assets under management
- $966MForm ADV private fund GAV, as of 2026-03-31Source (opens in a new tab)
- Latest fund size
- $172MSEC amount sold, vintage 2021
- Funds
- 4
- Legal name
- PETRICHOR HEALTHCARE CAPITAL MANAGEMENT LP
Claim, correct or request removal
Record updated 29 September 2026
About
Petrichor was launched in 2018 to support world-class healthcare managers and businesses. Our platform spans company formation through late-stage and commercial growth opportunities with a consistent long-term and strategic approach.
Investment approach
- Thesis
- Petrichor maintains a deep in-house understanding of biopharmaceutical and medical technology products and diagnostics. This scientific, technical, and commercial expertise helps us identify and actively facilitate the next generation of healthcare innovation.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- The team has led over 100 investments, representing more than $3 billion of capital invested, and has sat on over 60 boards.
- Investing status notes
- Provides growth capital to facilitate the adoption of healthcare innovations
Funds
- PETRICHOR SCION THERAPEUTICS LLC
- $172MVintage 2021, Main fund, SEC amount sold
- PETRICHOR OPPORTUNITIES FUND I LP
- Opportunity
- POF I CO-INVEST LP
- SPV
- PETRICHOR OPPORTUNITIES FUND I INTERMEDIATE LP
- Opportunity
SEC registration
- Registered adviser
- PETRICHOR HEALTHCARE CAPITAL MANAGEMENT LP
- CRD number
- 288664 (opens in a new tab)
- SEC file number
- 801-112209
- Registration
- SEC registered
- Regulatory AUM
- $966Mas of 2026-03-31
- Private funds reported
- 4
- Principal office
- NEW YORK, NY, United States
- SEC CIK
- 1893188
Locations
- Headquarters
- New York, NY, United States
Loading relationship preview